Alix K. Berglund

685 total citations
17 papers, 519 citations indexed

About

Alix K. Berglund is a scholar working on Genetics, Rehabilitation and Orthopedics and Sports Medicine. According to data from OpenAlex, Alix K. Berglund has authored 17 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 5 papers in Rehabilitation and 5 papers in Orthopedics and Sports Medicine. Recurrent topics in Alix K. Berglund's work include Mesenchymal stem cell research (8 papers), Tendon Structure and Treatment (5 papers) and Tissue Engineering and Regenerative Medicine (4 papers). Alix K. Berglund is often cited by papers focused on Mesenchymal stem cell research (8 papers), Tendon Structure and Treatment (5 papers) and Tissue Engineering and Regenerative Medicine (4 papers). Alix K. Berglund collaborates with scholars based in United States. Alix K. Berglund's co-authors include Lauren V. Schnabel, Douglas F. Antczak, Lisa A. Fortier, Brian C. Gilger, Lena Carlsson, Sten Hammarström, Julie M. Long, A. Hedin, Jessica M. Gilbertie and Matthew B. Fisher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Human Gene Therapy.

In The Last Decade

Alix K. Berglund

17 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alix K. Berglund United States 11 286 204 128 99 81 17 519
Anja Peterbauer-Scherb Austria 11 232 0.8× 284 1.4× 119 0.9× 95 1.0× 23 0.3× 11 540
Jettie Uyanne United States 5 506 1.8× 217 1.1× 141 1.1× 234 2.4× 92 1.1× 7 754
B. Ranera Spain 13 441 1.5× 279 1.4× 181 1.4× 120 1.2× 80 1.0× 19 635
Karthikeyan Rajagopal India 9 236 0.8× 163 0.8× 163 1.3× 66 0.7× 29 0.4× 18 504
Francisco José Vázquez Spain 15 546 1.9× 358 1.8× 173 1.4× 168 1.7× 99 1.2× 45 822
Mimmi Patrikoski Finland 11 353 1.2× 297 1.5× 108 0.8× 105 1.1× 19 0.2× 15 649
Ana Rosa Remacha Spain 13 536 1.9× 324 1.6× 161 1.3× 156 1.6× 88 1.1× 20 721
Xizhe Chen China 15 404 1.4× 296 1.5× 255 2.0× 109 1.1× 20 0.2× 33 794
Owen Marecic United States 12 179 0.6× 150 0.7× 396 3.1× 41 0.4× 41 0.5× 17 778
Jan C. Brune Germany 11 396 1.4× 233 1.1× 170 1.3× 71 0.7× 40 0.5× 41 759

Countries citing papers authored by Alix K. Berglund

Since Specialization
Citations

This map shows the geographic impact of Alix K. Berglund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alix K. Berglund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alix K. Berglund more than expected).

Fields of papers citing papers by Alix K. Berglund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alix K. Berglund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alix K. Berglund. The network helps show where Alix K. Berglund may publish in the future.

Co-authorship network of co-authors of Alix K. Berglund

This figure shows the co-authorship network connecting the top 25 collaborators of Alix K. Berglund. A scholar is included among the top collaborators of Alix K. Berglund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alix K. Berglund. Alix K. Berglund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Berglund, Alix K., et al.. (2024). IL-1β + TGF-β2 dual-licensed mesenchymal stem cells have reduced major histocompatibility class I expression and positively modulate tenocyte migration, metabolism, and gene expression. Journal of the American Veterinary Medical Association. 262(S1). S61–S72. 2 indexed citations
2.
Berglund, Alix K., et al.. (2023). Effect of gentamicin on CD3+ T‐lymphocyte proliferation for treatment of equine recurrent uveitis: An in vitro study. Veterinary Ophthalmology. 26(4). 347–354. 1 indexed citations
3.
Berglund, Alix K., et al.. (2023). A myristoylated alanine-rich C-kinase substrate (MARCKS) inhibitor peptide attenuates neutrophil outside-in β 2 -integrin activation and signaling. Cell Adhesion & Migration. 17(1). 1–16. 2 indexed citations
4.
Schnabel, Lauren V., et al.. (2022). TGF-β2 enhances expression of equine bone marrow-derived mesenchymal stem cell paracrine factors with known associations to tendon healing. Stem Cell Research & Therapy. 13(1). 477–477. 13 indexed citations
5.
Berglund, Alix K., et al.. (2022). Interleukin-1β in tendon injury enhances reparative gene and protein expression in mesenchymal stem cells. Frontiers in Veterinary Science. 9. 963759–963759. 12 indexed citations
6.
Schnabel, Lauren V., et al.. (2022). Defining the profile: Characterizing cytokines in tendon injury to improve clinical therapy. PubMed. 16. 100059–100059. 25 indexed citations
7.
8.
Linardi, Renata L., et al.. (2021). Effects of continuous passage on the immunomodulatory properties of equine bone marrow-derived mesenchymal stem cells in vitro. Veterinary Immunology and Immunopathology. 234. 110203–110203. 10 indexed citations
9.
Berglund, Alix K., Julie M. Long, James Robertson, & Lauren V. Schnabel. (2021). TGF-β2 Reduces the Cell-Mediated Immunogenicity of Equine MHC-Mismatched Bone Marrow-Derived Mesenchymal Stem Cells Without Altering Immunomodulatory Properties. Frontiers in Cell and Developmental Biology. 9. 628382–628382. 9 indexed citations
10.
Berglund, Alix K., Julie M. Long, & Lauren V. Schnabel. (2020). TGF-β downregulates MHC I surface expression through a Smad3-dependent mechanism. The Journal of Immunology. 204(1_Supplement). 140.2–140.2. 3 indexed citations
11.
Miller, Donald R., Alix K. Berglund, Lauren V. Schnabel, et al.. (2020). Cross-matching of allogeneic mesenchymal stromal cells eliminates recipient immune targeting. Stem Cells Translational Medicine. 10(5). 694–710. 32 indexed citations
12.
13.
Berglund, Alix K., Lisa A. Fortier, Douglas F. Antczak, & Lauren V. Schnabel. (2017). Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells. Stem Cell Research & Therapy. 8(1). 288–288. 173 indexed citations
14.
Gilger, Brian C., et al.. (2017). Effect of bone marrow-derived mesenchymal stem cells and stem cell supernatant on equine corneal wound healing in vitro. Stem Cell Research & Therapy. 8(1). 120–120. 42 indexed citations
15.
16.
17.
Hedin, A., Lena Carlsson, Alix K. Berglund, & Sten Hammarström. (1983). A monoclonal antibody-enzyme immunoassay for serum carcinoembryonic antigen with increased specificity for carcinomas.. Proceedings of the National Academy of Sciences. 80(11). 3470–3474. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anja Peterbauer-Scherb Breakdown of academic impact, for papers by Jettie Uyanne Breakdown of academic impact, for papers by B. Ranera Breakdown of academic impact, for papers by Karthikeyan Rajagopal Breakdown of academic impact, for papers by Francisco José Vázquez Breakdown of academic impact, for papers by Mimmi Patrikoski Breakdown of academic impact, for papers by Ana Rosa Remacha Breakdown of academic impact, for papers by Xizhe Chen Breakdown of academic impact, for papers by Owen Marecic Breakdown of academic impact, for papers by Jan C. Brune
Rankless by CCL
2026